BioSpace News Archive

Lysogene, a phase 3 gene therapy platform Company targeting central nervous system diseases, announced its 2020 full-year results, approved by the Board of Directors on 30 March 2021.

Oncopeptides AB announces that the number of shares and votes in Oncopeptides has changed due to the exercise of warrants under the company’s incentive program.

Transparency Market Research has published a new report titled, “Medical Sensors Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

TMR’s report on the global respiratory monitoring devices market studies past as well as current growth trends and opportunities to gain valuable insights for the said market during the forecast period i.e.

Transparency Market Research has published a new report titled, “Ultrasound Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

Premia Spine , a medical technology company aiming to change the way debilitating chronic leg and back pain is treated, today announced that its TOPS facet arthroplasty system won Breakthrough Device Designation from the U.S. Food & Drug Administration.

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a biopharmaceutical company focused on novel technologies including the targeting of infectious diseases, announced dosing the first human subject in its Phase I clinical trial evaluating ALS-4, an orally-administered small molecule drug for the treatment of infections caused by Staphylococcus

Delivering Seamless, Data-driven Intelligence Across the Episode of Care to Guide Informed Decision-making and Improve Outcomes

OMRON donates medical-grade nebulizers to support AAFA advocacy and education initiatives that aid the most vulnerable members of the asthma community

Takeda Pharmaceutical Company Limited announced the completion of its previously-announced sale of Takeda Consumer Healthcare Company Limited to Oscar A-Co KK, a company controlled by funds managed by The Blackstone Group Inc. and its affiliates for a total value of JPY 242.0 billion1.